ClavystBio

ClavystBio invests and partners with innovators, entrepreneurs, and founders to launch and grow global companies from Singapore.

ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into health impact. ClavystBio invests and partners with innovators, entrepreneurs, and founders, and fosters private and public partnerships, to launch and grow global companies from Singapore. Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds.